Labeler
Actavis Pharma, Inc. NDC Codes
Actavis Pharma, Inc. lists 288 finished drug products in the FDA NDC Directory under NDC labeler codes 0228, 0472, 0591, 45963, 62037.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- methylphenidate hydrochloride, Testosterone, Isotretinoin, metoprolol succinate, Perphenazine, Lamotrigine, guanfacine, Potassium Citrate, Desvenlafaxine, memantine hydrochloride, Celecoxib, Mesalamine, Solifenacin succinate, Doxepin, Doxycycline Hyclate
- Active ingredients
- Methylphenidate hydrochloride, Testosterone, Isotretinoin, Metoprolol succinate, Perphenazine, Lamotrigine, Guanfacine hydrochloride, Potassium citrate, Desvenlafaxine succinate, Celecoxib, Mesalamine, Solifenacin succinate
- NDC labeler codes
- 0228, 0472, 0591, 45963, 62037
- Strengths (from the 100 most recently listed products)
- Testosterone 10 mg/g; Testosterone 16.2 mg/g; Naloxone hydrochloride 4 mg/.1mL; Mifepristone 300 mg/1; Dalfampridine 10 mg/1; Scopolamine 1 mg/3d; Bexarotene 75 mg/1; Isotretinoin 40 mg/1; Isotretinoin 25 mg/1; Isotretinoin 35 mg/1; Isotretinoin 10 mg/1; Isotretinoin 20 mg/1; Isotretinoin 30 mg/1; Mesalamine 1000 mg/1; Alvimopan 12 mg/1; Methylphenidate hydrochloride 60 mg/1; Methylphenidate hydrochloride 10 mg/1; Methylphenidate hydrochloride 15 mg/1; Methylphenidate hydrochloride 20 mg/1; Methylphenidate hydrochloride 30 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Film coated, Extended release, Tablet, Extended release, Capsule, Gel, Capsule, Extended release, Tablet, Tablet, Delayed release, Injection, Powder, Lyophilized, For solution, Cream, Tablet, For suspension, Solution, Injection, Solution, Spray, Metered, System, Capsule, Liquid filled, Suppository, Powder, For suspension, Suspension, Ointment, Aerosol, Metered, Powder, For solution, Kit
- Routes
- Oral, Topical, Intravenous, Transdermal, Sublingual, Nasal, Rectal
- Drug classes (FDA established)
- Central Nervous System Stimulant, Retinoid, Androgen, Anti-epileptic Agent, Nonsteroidal Anti-inflammatory Drug, Central alpha-2 Adrenergic Agonist, beta-Adrenergic Blocker, Endothelin Receptor Antagonist, Phenothiazine, Mood Stabilizer, Corticosteroid, Anti-coagulant, Calculi Dissolution Agent, Serotonin and Norepinephrine Reuptake Inhibitor, Opioid Antagonist, Aminosalicylate, Cholinergic Muscarinic Antagonist, Tricyclic Antidepressant, Tetracycline-class Drug, Iron Chelator, N-methyl-D-aspartate Receptor Antagonist, Topoisomerase Inhibitor, Partial Opioid Agonist, Progestin Antagonist, Potassium Channel Blocker, Anticholinergic, Phosphodiesterase 5 Inhibitor, Antiparasitic, Pediculicide, Substance P/Neurokinin-1 Receptor Antagonist, Melatonin Receptor Agonist, Antirheumatic Agent, Antihistamine, Vitamin B6 Analog, Anthelmintic, Calcineurin Inhibitor Immunosuppressant, Muscle Relaxant, beta2-Adrenergic Agonist, Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor, Nucleoside Analog Antiviral, Lincosamide Antibacterial, Monoamine Oxidase Inhibitor, Vinca Alkaloid, Aminoketone, Nucleoside Metabolic Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 121 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| pimecrolimus | Pimecrolimus 10 mg/g | CreamTopical | 0591-2944 | 00591-2944-3000591-2944-6000591-2944-87 | — |
| azelaic acid | Azelaic acid .15 g/g | GelTopical | 0591-2131 | 00591-2131-55 | — |
| Ibuprofen | Ibuprofen 100 mg/5mL | SuspensionOral | 0472-2002 | 00472-2002-1600472-2002-94 | — |
| Budesonide | Budesonide 9 mg/1 | Tablet, Film coated, Extended releaseOral | 0591-2510 | 00591-2510-30 | — |
| Potassium Citrate | Potassium citrate 5 meq/1 | Tablet, Extended releaseOral | 0591-2682 | 00591-2682-01 | — |
| Potassium Citrate | Potassium citrate 10 meq/1 | Tablet, Extended releaseOral | 0591-2729 | 00591-2729-01 | — |
| Potassium Citrate | Potassium citrate 15 meq/1 | Tablet, Extended releaseOral | 0591-2742 | 00591-2742-01 | — |
| Mesalamine | Mesalamine 1.2 g/1 | Tablet, Delayed releaseOral | 0591-2245 | 00591-2245-22 | — |
| Testosterone | Testosterone 50 mg/5g | GelTransdermal | 0591-3524 | 00591-3524-30 | — |
| Testosterone | Testosterone 30 mg/1.5mL | SolutionTopical | 0591-2114 | 00591-2114-81 | — |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | 0591-2341 | 00591-2341-01 | — |
| Perphenazine | Perphenazine 2 mg/1 | Tablet, Film coatedOral | 0591-4101 | 00591-4101-01 | — |
| Perphenazine | Perphenazine 4 mg/1 | Tablet, Film coatedOral | 0591-4102 | 00591-4102-01 | — |
| Perphenazine | Perphenazine 8 mg/1 | Tablet, Film coatedOral | 0591-4103 | 00591-4103-01 | — |
| Perphenazine | Perphenazine 16 mg/1 | Tablet, Film coatedOral | 0591-4104 | 00591-4104-01 | — |
| Desvenlafaxine | Desvenlafaxine succinate 50 mg/1 | Tablet, Extended releaseOral | 0591-3659 | 00591-3659-30 | — |
| Desvenlafaxine | Desvenlafaxine succinate 100 mg/1 | Tablet, Extended releaseOral | 0591-3660 | 00591-3660-30 | — |
| Desvenlafaxine | Desvenlafaxine succinate 25 mg/1 | Tablet, Extended releaseOral | 0591-4060 | 00591-4060-30 | — |
| Fluocinolone Acetonide Topical | Fluocinolone acetonide .1 mg/mL | SolutionTopical | 0591-2990 | 00591-2990-60 | — |
| Desoximetasone | Desoximetasone 2.5 mg/g | OintmentTopical | 0472-0479 | 00472-0479-1500472-0479-60 | — |
| Levalbuterol tartrate HFA inhalationlevalbuterol tartrate | Levalbuterol tartrate 45 ug/1 | Aerosol, MeteredOral | 0591-2927 | 00591-2927-54 | — |
| Valganciclovir hydrochloride for Oralvalganciclovir hydrochloride | Valganciclovir hydrochloride 50 mg/mL | Powder, For solutionOral | 0591-2579 | 00591-2579-20 | — |
| Clindamycin Phosphate and Tretinoin | Clindamycin phosphate 12 mg/g; Tretinoin .25 mg/g | GelTopical | 0472-1790 | 00472-1790-3000472-1790-60 | — |
| Lamotrigine | Lamotrigine 250 mg/1 | Tablet, Film coated, Extended releaseOral | 0228-1638 | 00228-1638-03 | — |
| Diclofenac Sodium | Diclofenac sodium 30 mg/g | GelTopical | 0472-1783 | 00472-1783-10 | — |
| Lamotrigine | Lamotrigine 100 mg/1 | Tablet, Film coated, Extended releaseOral | 0228-1422 | 00228-1422-03 | — |
| Lamotrigine | Lamotrigine 200 mg/1 | Tablet, Film coated, Extended releaseOral | 0228-1453 | 00228-1453-03 | — |
| Lamotrigine | Lamotrigine 300 mg/1 | Tablet, Film coated, Extended releaseOral | 0228-1580 | 00228-1580-03 | — |
| Tranylcypromine Sulfate | Tranylcypromine sulfate 10 mg/1 | Tablet, Film coatedOral | 0591-5590 | 00591-5590-01 | — |
| Testosterone | Testosterone 10 mg/g | GelTopical | 0591-2921 | 00591-2921-02 | — |
| Testosterone | Testosterone 10 mg/g | GelTopical | 0591-3216 | 00591-3216-30 | — |
| Testosterone | Testosterone 10 mg/g | GelTopical | 0591-3217 | 00591-3217-30 | — |
| Clonidine Hydrochloride | Clonidine hydrochloride .1 mg/1 | Tablet, Extended releaseOral | 0228-4241 | 00228-4241-06 | — |
| memantine hydrochloride | — | KitOral | 0591-3900 | 00591-3900-87 | — |
| memantine hydrochloride | Memantine hydrochloride 5 mg/1 | TabletOral | 0591-3870 | 00591-3870-4400591-3870-60 | — |
| memantine hydrochloride | Memantine hydrochloride 10 mg/1 | TabletOral | 0591-3875 | 00591-3875-4400591-3875-60 | — |
| Celecoxib | Celecoxib 50 mg/1 | CapsuleOral | 0591-3982 | 00591-3982-60 | — |
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | 0591-3983 | 00591-3983-0100591-3983-05 | — |
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | 0591-3984 | 00591-3984-0100591-3984-05 | — |
| Irinotecan hydrochloride | Irinotecan hydrochloride 20 mg/mL | Injection, SolutionIntravenous | 45963-614 | 45963-0614-5145963-0614-55 | — |
| Vinorelbine | Vinorelbine tartrate 10 mg/mL | Injection, SolutionIntravenous | 45963-607 | 45963-0607-5545963-0607-56 | — |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | 0228-3153 | 00228-3153-03 | — |
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | 0228-3156 | 00228-3156-03 | — |
| Bupropion Hydrochloride | Bupropion hydrochloride 300 mg/1 | Tablet, Extended releaseOral | 45963-142 | 45963-0142-0545963-0142-3045963-0142-90 | — |
| Fludarabine phosphate | Fludarabine phosphate 50 mg/2mL | Injection, Powder, Lyophilized, For solutionIntravenous | 45963-609 | 45963-0609-55 | — |
| Topotecan hydrochloride | Topotecan hydrochloride 4 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 45963-615 | 45963-0615-56 | — |
| guanfacine | Guanfacine hydrochloride 1 mg/1 | Tablet, Extended releaseOral | 0228-2850 | 00228-2850-11 | — |
| guanfacine | Guanfacine hydrochloride 2 mg/1 | Tablet, Extended releaseOral | 0228-2851 | 00228-2851-11 | — |
| guanfacine | Guanfacine hydrochloride 3 mg/1 | Tablet, Extended releaseOral | 0228-2853 | 00228-2853-11 | — |
| guanfacine | Guanfacine hydrochloride 4 mg/1 | Tablet, Extended releaseOral | 0228-2855 | 00228-2855-11 | — |
Actavis Pharma, Inc.: common questions
- What is Actavis Pharma, Inc.'s NDC labeler code?
- 0228, 0472, 0591, 45963, 62037. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Actavis Pharma, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.